Business
RenovaCare 2018 Outlook and Shareholder Update from the CEO
RenovaCare 2018 Outlook and Shareholder Update from the CEO.
About this update from Renovacare, Inc.
[{"type":"text","content":"\n \n RenovaCare, Inc., (OTCQB: RCAR), developer of the SkinGun™ and CellMist™ \n System for isolating and spraying a patient’s own stem cells onto burns \n and wounds for rapid self-healing, is pleased to provide its outlook for \n 2018, which includes a shareholder update on the Company’s plans to \n advance its products towards market.\n \n\nThis press release features multimedia. View the full release here: \nhttp://www.businesswire.com/news/home/20180109005430/en/\n\n \n \n RenovaCare SkinGun™ Sprays Stem Cells to Heal Burns and Wounds (Photo: Business Wire) \n\n\n \n January 9, 2018\n \n \n Dear Valued Shareholders and Supporters:\n \n \n By every measure, 2017 was an amazing year for RenovaCare, Inc. (Symbol: \n RCAR). And, we expect 2018 to be even better, with the next major \n milestone being our initial FDA filing.\n \n \n This long-awaited FDA filing will advance our breakthrough technology \n towards market. As I said, 2018 is going to be fantastic for us and all \n of our shareholders and supporters.\n \n \n Last year, our team achieved a lot. We had studies in prestigious \n journals and even miniaturized the SkinGun™ from the size of a microwave \n to a device that fits comfortably in one hand.\n \n \n Along the way, we were featured on Bloomberg, National Geographic, \n Newsweek, among many others, and written about by Tony Robbins in his \n bestselling book, Money Master the Game.\n \n \n Rapid Self-Healing in Just 90 Minutes\n \n \n By spraying a person’s own skin stem cells for rapid self-healing, we \n are developing a much-needed alternative for the tens of millions who \n suffer from severe burns and wounds worldwide.\n \n \n Based on early case studies, patients can be treated within 90 minutes \n of arriving at a hospital, where their own skin stem cells are quickly \n isolated and gently sprayed on to wound sites for fast healing.\n \n \n Skin stems cells sprayed with our patented SkinGun™ device maintain \n 97.3% cell viability, with no impairment to cell growth or metabolic \n activity when evaluated in vitro.\n \n \n While this might be impressive, more impressive have been the actual \n treatment results.\n \n \n 72 Patients Treated to Date\n \n \n To date, a total of 72 patients have been treated, with 45 in \n Pittsburgh, PA, and 27 in Berlin (German...